CoChat

Nuclear Factor Kappa B: Important Transcription Factor and Therapeutic Target

Lee, Jang‐Ik, Burckart, Gilbert J. · 1998 · The Journal of Clinical Pharmacology
Cited by 365

The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.

Abstract

Nuclear factor kappa B (NF‐κB) is an ubiquitous rapid response transcription factor in cells involved in immune and inflammatory reactions, and exerts its effect by expressing cytokines, chemokines, cell adhesion molecules, growth factors, and immunoreceptors. In this manner, NF‐κB contributes to immunologically mediated diseases such as allograft rejection, rheumatoid arthritis, and bronchial asthma. The prototypic inducible form of NF‐κB is a heterodimer composed of NF‐kB1 and RelA, which both belong to the NF‐κB/Rel family of proteins. Inactive NF‐κB is present in the cytoplasm complexed with an inhibitory protein, IκB. NF‐κB is activated by a number of incoming signals from the cell surface. Released from IκB inhibition, NF‐κB translocates into the nucleus and binds to the κB motif of the target gene. The NF‐κB activation process can be inhibited by pharmacologic agents at each activation step. Glucocorticoids inhibit NF‐κB by directly associating with NF‐κB or by upregulating IκB expression. Cyclosporin and tacrolimus prevent NF‐κB activation by inhibiting the action of calcineurin, a phosphatase that indirectly induces IκB degradation. Deoxyspergualin inhibits NF‐κB by blocking its nuclear translocation. Aspirin and salicylates inhibit upstream events inducing IκB phosphorylation. Tepoxalin and antioxidants inhibit NF‐κB activation by influencing the redox state of the cell. Further research is required to develop more specific inhibitors to treat diseases mediated by NF‐κB.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/009127009803801101

Cites

81 of 81 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 365

Metadata

Authors
Lee, J., & Burckart, G. J.
Venue
The Journal of Clinical Pharmacology
Publisher
Wiley
Published
1998-11
Volume
38
Issue
11
Pages
981-993
ISSN
  • 0021-9754 (ISSN-L)
  • 0091-2700
  • 1552-4604
OpenAlex
W1963709111
Cited by
365
References
81
FWCI
6.16
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.